C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof

Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/2006
12/05/2006	CA2434386C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/05/2006	CA2387531C Purine derivatives
12/05/2006	CA2345624C Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound
11/2006
11/30/2006	WO2006127906A1 Heterobifunctional compounds for selectin inhibition
11/30/2006	WO2006127009A1 Reagent for the improved synthesis of isoguanosine-containing oligonucleotides
11/30/2006	WO2006063717A3 Polymerase-independent analysis of the sequence of polynucleotides
11/30/2006	US20060270840 Pentopyranosyl nucleic acid conjugates
11/30/2006	US20060270624 Gapped 2' modified oligonucleotides
11/30/2006	US20060269958 UV excitable energy transfer reagents
11/30/2006	CA2609622A1 Reagents for the improved synthesis of isoguanosine-containing oligonucleotides
11/30/2006	CA2601554A1 Compounds and methods for labeling oligonucleotides
11/29/2006	EP1726597A1 NOVEL ARTIFICIAL RNAóS MODIFIED AT THE 2ó-HYDROXYL GROUP
11/29/2006	EP1725572A2 Macromolecular nucleotide compounds and methods for using the same
11/29/2006	EP1390545B1 Device and biological sample processing methods
11/29/2006	EP1186612B1 Process for the preparation of cytidine derivatives
11/29/2006	EP1088066B1 Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues
11/29/2006	CN1871250A Nucleoside compounds for treating viral infections
11/29/2006	CN1286845C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV)
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141557 Lipid analogs for treating viral infections
11/28/2006	US7141553 A3AR agonists for the treatment of inflammatory arthritis
11/28/2006	US7141397 Method of preparing a guanosine-group compound and an intermediate thereof
11/28/2006	US7141396 Method of preparing a guanosine-group compound and an intermediate thereof
11/28/2006	CA2379786C Purine derivatives
11/23/2006	WO2006125211A1 A1 adenosine receptor agonists
11/23/2006	WO2006125190A1 A1 adenosine receptor agonists
11/23/2006	US20060264397 Compositions and methods for targeting cancer cells
11/23/2006	US20060264390 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/23/2006	US20060264389 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/23/2006	US20060263859 Method for preparing 3'-amino-2',3'-dideoxyguanosine
11/23/2006	CA2609117A1 A1 adenosine receptor agonists
11/23/2006	CA2609051A1 A1 adenosine receptor agonists
11/22/2006	EP1724254A2 Novel compositions for the delivery of negatively charged molecules
11/22/2006	EP1722818A2 Photoreactive compound specifically binding to calcium binding proteins
11/22/2006	EP1644395B1 Processes for preparing 4'azido nucleoside derivatives
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	CN1867575A Process for the preparation of fludarabine phosphate
11/22/2006	CN1864696A New formulation
11/22/2006	CN1285605C Antitumour indolo pyrrolo carbazole derivatives
11/21/2006	US7138517 Sugar modified oligonucleotides
11/21/2006	US7138385 Thioarabinofuranosyl compounds and use thereof
11/21/2006	US7138383 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity
11/21/2006	US7138377 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
11/21/2006	US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	CA2302156C Methods for modulating the axonal outgrowth of central nervous system neurons
11/16/2006	WO2006122207A1 6-hydrazinopurine 2'-methyl ribonucleosides and nucleotides for treatment of hcv
11/16/2006	WO2006121856A2 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
11/16/2006	WO2006121820A1 Phosphoramidate prodrugs for treatment of viral infection
11/16/2006	WO2006121468A1 5-nitro-nucleoside compounds for treating viral infections
11/16/2006	US20060258614 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
11/16/2006	US20060258613 6-Oxyamino-7-deazapurin-9-yl-2-substituted ribofuranose derivatives, e.g., 1-(6-hydroxylamino-7-ethenyl-7-deazapurin-9-yl)-2-methyl- beta -D-ribofuranose; treating viral infections mediated by a virus in the flaviviridae family
11/15/2006	EP1721907A1 Silyl linker for solid-phase synthesis of nucleic acid
11/15/2006	EP1720891A1 Crystalline forms of a pharmaceutical compound
11/15/2006	EP1720890A2 Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
11/15/2006	EP1720556A2 Novel 2'-c-methyl nucleoside derivatives
11/15/2006	EP0931078B1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
11/15/2006	EP0601092B2 Method for the selection of genetically transformed cells and compounds for use in the method
11/15/2006	CN1863813A Novel tricyclic nucleosides or nucleotides as therapeutic agents
11/15/2006	CN1863812A Polymorphic antiviral nucleoside compounds
11/15/2006	CN1863538A Nucleoside derivatives for treating hepatitis c virus infection
11/15/2006	CN1861625A Crystallization process of 5'-nucleoside sodium triphosphate
11/15/2006	CN1861624A Crystallization process of 5'-nucleoside-sodium phosphate
11/14/2006	US7135584 Herpes, hepatitis, and aids virus; administering phosphatides
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/09/2006	WO2006119347A1 STEREOSELECTIVE SYNTHESIS OF β-NUCLEOSIDES
11/09/2006	WO2006117161A2 New labelling strategies for the sensitive detection of analytes
11/09/2006	WO2006082058A3 Cell-free translation system for the production of (chemically) modified proteins
11/09/2006	US20060252924 Useful in the highly parallel, microscale synthesis of oligonucleotides
11/09/2006	US20060252923 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
11/09/2006	US20060252715 Tricyclic-nucleoside compounds for treating viral infections
11/09/2006	US20060252115 Synthesis and use of anti-reverse mRNA cap analogues
11/09/2006	US20060252038 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry
11/09/2006	CA2607530A1 New labelling strategies for the sensitive detection of analytes
11/08/2006	EP1718659A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same
11/08/2006	EP1242438B1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
11/08/2006	EP1001035B9 Novel antibiotics rk-1061 and process for preparing the same
11/08/2006	CN1860364A Fluorescently tagged ligands
11/07/2006	US7132409 2-(6-cyano-1-hexyn-1-yl)adenosine; 2(6-cyano-1-hexyn-1yl)adenosine 5' phosphate or salts; for lowering ocular tension, promoting blood flow in retina, protecting optic nerve failure; for treament of glaucoma and ocular hypertension
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006	CA2376860C Dinucleotide crystals
11/02/2006	WO2006116557A1 Nucleoside compounds for treating viral infections
11/02/2006	WO2006116512A1 Nucleoside compounds and methods of use thereof
11/02/2006	WO2006115137A1 2-aminobenzimidazole derivative and use of the same for medical purposes
11/02/2006	WO2006114336A1 Fluorinated 3'-deoxythymidine derivatives, a method for their preparation and their use
11/02/2006	US20060247433 using 1-beta-D-arabinofuranosyluracil in 3',5'-hydroxyl-protected form as substrate, target trifluoromethanesulfonylation at 2'-position and subsequent nucleophilic SN2 substitution reaction by fluorine anion (F-) at 2'-position proceed well under specific conditions
11/02/2006	US20060247432 Synthesis of 5-Azacytidine
11/02/2006	US20060247416 HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
11/02/2006	US20060247189 Forms of 5-Azacytidine
11/02/2006	US20060247188 Effective treatment of tumors and cancer with triciribine and related compounds
11/02/2006	US20060247155 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/02/2006	US20060242770 Xyloglucan conjugates useful for modifying cellulosic textiles
11/02/2006	EP1284984B1 Uridine derivatives as antibiotics
11/02/2006	EP1058686B1 2'-fluoronucleosides
11/02/2006	CA2609342A1 Nucleoside compounds and methods of use thereof
11/01/2006	CN1856314A Farmaceutiske kombinationer af adenosin A-2a- og beta-2-adrenerge receptoragonister
10/2006
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129338 polynucleotide that code for proteins used for developing drugs or as target molecules for drugs; nervous system disorders
10/31/2006	US7129308 Functionalized silicon compounds and methods for their synthesis and use

1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 201